Exicom Tele-Systems Ltd Q1 FY27 Results

Exicom delivered record 61% consolidated revenue growth and ₹1,400 Cr order book, supporting the 2–3 year structural narrative in energy transition (5G, EV, BESS). However, Q1 reported a -₹73.6 Cr consolidated loss, with PAT deteriorating QoQ by 35.5% despite revenue growth—driven by Hyderabad capex (₹10.3 Cr depreciation, ₹8.7 Cr parallel run costs) and Tritium inventory margin normalization. The core risk: management targets EBITDA/PAT breakeven in next 2 quarters (Q2–Q3 FY27), but this is unproven and timing is vague; if costs extend or Tritium trials stall, the loss could persist into H2.

Analysts pressed hard on EBITDA deterioration (Taksh Gaur: broke even Q4, -₹22.5 Cr in Q1 despite 61% growth). Management blamed Q4 seasonality + Tritium inventory normalization but timeline vague. Suraj C questioned capacity numbers and depreciation levels; management partly deferred ('I'll come back to you'). Shashi Kant probed EV charger underutilization industry issue; management pivoted to product quality narrative, avoiding direct answer on macro headwinds. Overall: held up but cautious tone among analysts.

Score 6/10. Confident but sometimes vague. Acknowledged challenges (Hyderabad costs, Tritium inventory normalization) candidly. But specific timelines often hedged ('next 2 quarters', 'I'll follow up'). Capacity expansion numbers were inconsistent initially (clarified later). Mixed track record. Delivered 61% revenue growth and ₹1,400 Cr order book (strong). But consolidated profitability has deteriorated QoQ despite growth, missing implied guidance momentum. Tritium turnaround is 2+ years old; trials still mid-stage, not yet converted to contracts.

Exicom's Q1 FY27 (quarter ended June 30, 2026) consolidated revenue grew 61.3% YoY to ₹331.07 Cr from ₹205.32 Cr, but fell 14.7% QoQ from Q4 FY26's seasonally strong ₹387.95 Cr. The company stayed loss-making at the consolidated level: net loss of ₹73.57 Cr versus ₹54.31 Cr in Q4 FY26 (35.5% wider sequentially). Against Q1 FY26's reported loss of ₹83.14 Cr this reads as an 11.5% narrower loss, but that comparison is distorted by a ₹12.05 Cr one-off exceptional charge embedded in the year-ago numbers; stripping it out, the adjusted year-ago loss was ~₹71.08 Cr, meaning the underlying loss this quarter is essentially flat to marginally wider YoY (~3.5%) rather than a genuine improvement. Standalone, in contrast, posted a profit of ₹4.92 Cr (EPS ₹0.35), continuing the pattern of a profitable domestic Critical Power business offset by loss-making overseas EV-charging subsidiaries at the consolidated level.

Consolidated net margin came in at -21.9%, worse than Q4 FY26's -13.9% though better than Q1 FY26's -38.9%. The segments explain why: Critical Power, the profitable core, grew revenue 72.9% YoY to ₹177.21 Cr and segment profit 132.8% YoY to ₹12.77 Cr, delivering on management's prior guidance of "steady, profitable growth" for that business — though its QoQ dip (segment PBT was ₹21.38 Cr in Q4 FY26) suggests part of Q4's strength was seasonal, tied to year-end telecom capex. The EV Charger segment, which houses Tritium, grew revenue 49.6% YoY to ₹153.86 Cr, but its segment loss widened to ₹68.60 Cr from ₹60.68 Cr a year ago and ₹54.21 Cr last quarter — the opposite of the trajectory needed to hit management's stated Q4 FY27 EBITDA-breakeven target for Tritium. Rising depreciation (₹38.96 Cr, +56.9% YoY, tied to the new Hyderabad plant ramp-up) and employee costs (₹50.09 Cr, +43.2% YoY) added further pressure on consolidated margins even as revenue scaled.

The stock went into the print at ₹152.36, down 10.4% over the past month of trading.

Management's May 2026 (Q4 FY26) concall struck a confident, optimistic tone, projecting EV-charging-led revenue growth via Tritium's scale-up and the Hyderabad plant alongside steady profitable growth in Critical Power, while flagging near-term working-capital build-up and BESS import-supply constraints as risks. This quarter delivers on the Critical Power half of that guidance but not on the Tritium trajectory — the segment loss moved in the wrong direction despite the revenue scale-up, so the print reads as a miss against the breakeven glide-path management described, even though the FY27 (Q4) deadline is still two quarters out. No brokerage consensus estimates for this specific quarter turned up in a web search, so the print cannot be benchmarked against street numbers here. The filing itself carries no accompanying management commentary or press release — only the regulatory board-outcome letter — so there is no fresh company framing to reconcile against the numbers. Separately, the board approved related-party transactions between overseas subsidiaries (subject to AGM approval), and Exicom B.V.'s conversion of $1.5M in OCDs during the quarter diluted the parent's stake in that subsidiary to 90.29% — a structural item, not a P&L driver this quarter.